Intrauterine growth restriction modifies gene expression profiling in cord blood

Taketoshi Yoshida1, Ichiro Takasaki, Hirokazu Kanegane

  • 1Division of Neonatology, Maternal and Perinatal Center, Toyama University Hospital, Toyama, Japan.

Insights

Gene expression changes in cord blood of small-for-gestational-age (SGA) newborns are linked to future metabolic syndrome risks. This study identifies specific gene alterations during the fetal period, offering insights into long-term health outcomes.

Area of Science:

  • Genetics
  • Neonatology
  • Metabolic Health

Background:

  • Small-for-gestational-age (SGA) newborns face higher risks of perinatal issues and adult metabolic diseases like cardiovascular disease and type 2 diabetes mellitus (T2DM).
  • The underlying mechanisms for these increased risks in SGA infants are not fully understood.
  • This research investigates fetal genetic modifications in SGA newborns via cord blood analysis.

Purpose of the Study:

  • To characterize fetal changes in small-for-gestational-age (SGA) newborns.
  • To identify specific gene expression alterations in the cord blood of SGA infants.
  • To explore the potential link between fetal gene expression and later metabolic syndrome development.

Main Methods:

  • Compared gene expression in cord blood between 10 SGA and 10 appropriate-for-gestational-age (AGA) newborns using microarray analysis.
  • Utilized Ingenuity Pathways Knowledge Base for pathway analysis of identified genes.
  • Confirmed microarray findings for upregulated genes in SGA newborns using quantitative real-time polymerase chain reaction (RT-PCR).

Main Results:

  • Identified 775 upregulated and 936 downregulated probes in SGA newborns compared to AGA newborns.
  • Annotated 1149 of the identified probes, with most genes linked to cardiovascular disease and T2DM development.
  • Demonstrated good agreement between microarray analysis and RT-PCR results for gene expression validation.

Conclusions:

  • Observed modified gene expression in the fetal period of SGA newborns.
  • Highlighted that these altered genes are associated with metabolic syndrome.
  • Proposed long-term follow-up of SGA newborns to examine the link between cord blood gene expression and adult metabolic syndrome vulnerability, using cord blood gene expression as a non-invasive investigative tool.
Abstract